SaaS Transition And AI Partnerships Will Expand Healthcare Reach

AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Published
11 Apr 25
Updated
17 Jul 25
AnalystConsensusTarget's Fair Value
US$3.38
14.5% overvalued intrinsic discount
17 Jul
US$3.87
Loading
1Y
197.7%
7D
3.5%

Author's Valuation

US$3.4

14.5% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on24 Apr 25
Fair value Decreased 26%

AnalystConsensusTarget has decreased future PE multiple from 170839.2x to 125886.1x.

Shared on17 Apr 25
Fair value Increased 22%

AnalystConsensusTarget has increased revenue growth from 10.7% to 12.3%, decreased profit margin from 14.1% to 0.0% and increased future PE multiple from 37.3x to 170839.2x.